|
 |
| |
| Slide
10 of 22 |
| |
Speaker
notes: Now in the presence of a second PI, namely ritonavir,
P-glycoprotein (in enterocytes) and CYP3A4 (in enterocytes and liver)
are inhibited, leading to:
-
increased
half life
- possibly
increased Cmax, depending on which PI is co-administered with
ritonavir
- increased
total exposure.
Thus PI levels
are above the required plasma concentration at the end of the dosing
interval, and the inhibitory quotient (IQ) of the drug that is combined
with RTV becomes more favourable. |

Copyright © 1999- The University of Liverpool.
All rights reserved. Site developed and maintained
by The University of Liverpool and
|